World Health Organization Chief Scientist Soumya Swaminathan.

Photo: Interview Times

WHO Top Scientist: India To Become World's Biggest Pharmacy

World Health Organization Chief Scientist Soumya Swaminathan has praised India for becoming the pharmacy of the world in the last 75 years. She enumerated India's four major successes that are eradication of polio, a few other vaccine-preventable diseases, the reduction of maternal and child mortality, and universal health coverage. However, she said, "The Covid-19 pandemic has also increased the poverty'll need to...take… read-more

Sun, 03 Oct 2021 - 02:46 PM / by Vidhi Jhunjhunwala

Tags: India, Pharmacy, World Health Organisation, Scientist

Courtesy: NDTV

Pharmaceutical products

Photo: The Economic Times

Indian Pharma Exports Clock 18% Growth In FY20-21; Highest In 8 Years

India has recorded a steep growth of 18.07% in drugs and pharmaceutical exports, said Pharmaceutical Export Promotion Council of India (Pharmexcil). According to the Department of Commerce, Government of India, for the financial year 2020-21, India exported pharmaceutical goods worth $24.44 billion which is the highest export in the past eight years. Despite the pharmaceutical market showing a decline of 1-2% in 2020 globally, the demand for… read-more

Sat, 17 Apr 2021 - 06:35 PM / by Nikita Thakur

Tags: Brifly News, Brifly Exclusive, Pharmacy, Exports, Pharmaceutical Exports

Courtesy: Brifly Exclusive

Prostate Cancer

Photo: Medlife

BDR Pharma's Prostate Cancer Drug to be Available in 80mg in India

BDR Pharma announced that its prostate cancer drug, Enzalutamide, will be available in 80mg in India to reduce the pill burden on patients. The tablets are used to treat men with metastatic Castration-Resistant Prostate Cancer (mCRPC) and are priced at Rs 24,480 per pack, consisting of four strips. Earlier, in 2017, BDR Pharma had received authorization from the Drug Controller General of India (DCGI) for its 40mg version of Enzalutamide.

Tue, 22 Sep 2020 - 12:05 PM / by Sneha Ramesh

Tags: health care, Cancer, drug, Pharmacy

Courtesy: The Economic Times

Covid drug Coronavir has been approved by Russia to hit the markets.

Photo: Clinical Trials Arena

Russia Approves First Prescription Drug To Treat Mild and Moderate COVID-19 Symptoms

In a bid to control COVID-19, Russia has authorized R-Pharm's 'Coronavir' as a prescription drug for the treatment of Coronavirus. Reportedly, the drug can be used to treat COVID-19 patients with mild and moderate symptoms and the company is planning to make it available in pharmacies by next week. Russia is the first nation to have approved a prescription drug for Coronavirus.

Sat, 19 Sep 2020 - 01:38 PM / by Sneha Ramesh

Tags: Coronavirus, coronavirus treatment, Pharmacy, COVID-19 DRUG

Courtesy: The Economic Times


Photo: PVRI

USFDA Approves 'Treprostinil' Injection to Treat Pulmonary Arterial Hypertension

US Food and Drug Administration (USFDA) has given preliminary approval for the Treprostinil injection, which aims to treat pulmonary arterial hypertension. The drug is produced by the subsidiary of Alembic Pharmaceuticals and is expected to be equivalent to Remodulin Injection. Patients with pulmonary arterial hypertension experience high blood pressure in arteries that go from the heart to the lungs.

Tue, 08 Sep 2020 - 09:28 AM / by Sneha Ramesh

Tags: health care, food and drug administration, Pharmacy, United States

Courtesy: The Economic Times

Lung cancer

Photo: Outlook India

US FDA Approves Oral Drug 'Gavreto' to Treat Lung Cancers

The lung cancer drug, Gavreto, on September 5 has passed the approval standards of the US Food and Drug Administration (USFDA). The drug, developed by Roche Holding AG in collaboration with Blueprint Medicines Corp, is intended to treat patients with Non-Small Cell Lung Cancer (NSCLC). Gavreto is an oral RET-targeted therapy. Reportedly, it is designed to selectively inhibit RET alterations… read-more

Mon, 07 Sep 2020 - 08:40 AM / by Sneha Ramesh

Tags: health care, Lung Cancer, Pharmacy, food and drug administration

Courtesy: The Economic Times


Photo: Mylan Laboratories

Mylan Drug Plant at Telangana Not Maintaining Standards: US FDA

The Mylan Laboratories Ltd's Unit 7 is deviating from the Current Good Manufacturing Practices(CGMP), warned the US Food and Drug Administration (FDA). The FDA, in its letter to Mylan, said that the company had not followed adequate cleaning measures and testing of raw materials for impurities; this could contaminate the materials that are used to produce medicines. The plant is located in the Sangareddy district of Telangana.

Sun, 06 Sep 2020 - 08:19 AM / by Sneha Ramesh

Tags: Telangana, Pharmacy, United States, food and drug administration

Courtesy: The Economic Times

Amazon India

Photo: Pharmacy Business

Bangalore: Amazon to Deliver Medicines through Online, Launches E-pharmacy

Amazon has launched 'Amazon E-pharmacy' services in Bangalore, amid the ongoing Covid-19 pandemic. Amazon is now expected to compete against NetMeds, Medlife, PharmEasy, and others. The Amazon Pharmacy service will offer prescription-based medicines, over-the-counter and traditional Ayurveda medicines, as well as basic health devices. "It will help customers meet their essential needs while staying safe at home,” said Amazon Spokesperson.

Sat, 15 Aug 2020 - 01:55 AM / by Shibu Immanuel S

Tags: Amazon, Covid-19, Pharmacy, Bangalore

Courtesy: The News Minute